James H. Quigley, Director at MERRIMACK PHARMACEUTICALS INC (MACK), bought 12,500 shares at $7.55 ($94K) on 2012-08-24, disclosed to the SEC on 2012-08-27.
Open-market purchase of $94k MACK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.50 | 300 | $2K | 2.4% |
| 2 | $7.55 | 12,200 | $92K | 97.6% |
| Total | $7.55 avg | 12,500 | $94K | 100% |
| Filing → |
| HES | BUY | 2017-03-02 | $25K | — | Filing → |
| WFC | BUY | 2016-05-04 | $100K | — | Filing → |
| HES | BUY | 2016-03-03 | $25K | — | Filing → |